Zydus Lifesciences (ZYDUSLIF IN): Strong Start of FY24 Riding on US Formulation Business
Quarterly revenue surpassed INR50B mark for 2nd consecutive quarter. Even upon a high base, US revenue increased 8% sequentially driven by new...
771 Views
Pick of the Week - CIPLA LTD - 14 AUG 2023
Cipla is a global pharmaceutical company focused on agile and sustainable growth, complex generics and portfolio deepening in the India, South...
259 Views
Sun Pharmaceutical (SUNP IN): Q1 Profit Falls Due to One-Off Expenses; Double-Digit Revenue Growth
Sun Pharma reported 11% sales growth to INR118B in Q1, driven by the US business. Net profit declined 2% to INR20B due to one-off charges....
430 Views
Dr. Reddy's Laboratories (DRRD IN): Q1FY24 Result- US Business Shines; PAT Jumps 18%
North America sales grew 79% y/y and 26% q/q to INR32 billion, driven by new product launches, continued momentum in existing products, favorable...
483 Views
CIPLA Ltd - Robust Performance Across All Parameters
Cipla reported the highest-ever US business of $222 Mn (+26% QoQ), which was primarily led by better execution in the base business and a higher...
403 Views